DSpace Repository

THE ROLE OF PROBIOTICS IN LIVER CIRROSIS

Show simple item record

dc.contributor.author Alisher M. Urinov, Ilkhom O. Otajonov ,Dilafruz B. Akhmedova .
dc.date.accessioned 2023-02-24T10:10:49Z
dc.date.available 2023-02-24T10:10:49Z
dc.date.issued 2023
dc.identifier.issn 2515-8260
dc.identifier.uri http://repository.tma.uz/xmlui/handle/1/6421
dc.description.abstract The frequency of cirrhosis is about 20–40 cases per 100,000 populations, and this indicator is steadily increasing. At present, it is one of the six main causes of death at the age of 35–60 years in economically developed countries. Foreign and domestic scientists are working on the development and synthesis of new drugs of chemical and natural origin for the treatment and prevention of liver diseases of various origins, in particular liver cirrhosis. Many studies have shown an important pathogenic role in the occurrence and progression of some liver diseases with changes in the intestinal microbiota. Therefore, antibiotics, prebiotics and probiotics are an effective treatment for liver diseases, which can correct the intestinal microbiota. en_US
dc.language.iso en en_US
dc.subject liver disease probiotics liver cirrhosis treatment en_US
dc.title THE ROLE OF PROBIOTICS IN LIVER CIRROSIS en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account